Live Breaking News & Updates on Study With Full Recovery

SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Angelos Stergiou , Bruce Mackle , Drug Administration , Lifesci Advisors , Memorial Sloan Kettering Cancer Center , Life Sciences Group Inc , Genfleet Therapeutics Shanghai Inc , Life Sciences Receives , Sciences Receives , Track Designation , Refractory Acute Myeloid Leukemia , Provides Updated Data , Enrollment Completed , Safety Cohort , Median Overall Survival , Not Reached , Patients Alive , Significant Antileukemic Effect Observed , Evaluable Patients , Enrolled Patient , Study Achieved Complete Remission , Study With Full Recovery , Seventh Month , Second Enrolled Patient Continues , Sixth Month , Acute Myeloid Leukemia ,